To verify the diagnostic capacity of S100A9 and TNC levels in distinguishing CRC from other benign intestinal diseases, such as colon polyps and inflammatory bowel disease, ROC curves and dot plots were constructed (Fig. 1a, b; Fig. 2b). This evidence concerns the gene S100A9 and colorectal carcinoma.